The system will be down for regular maintenance from 8:00-10:00am PDT on April 3rd, 2024.
Search
Now showing items 1-1 of 1
Intracellular Delivery of Cancer-Targeting Antibody-Drug Conjugates
(2013-11-14)
The use of cancer targeted antibody-drug conjugates aims to reduce the adverse affects of current therapies by selectively seeking and destroying tumor cells. Current systems employ targeted monoclonal antibodies conjugated to chemotoxins which have good cancer cell specificity, but suffer from early decomposition, normal ...